Stiftingtalstraße 14 | 8010 Graz, Austria

RIPK3 Restricts Myeloid Leukemogenesis by Promoting Cell Death and
Differentiation of Leukemia Initiating Cells. Cancer Cell. 2016

Share:

More Posts

At Cycuria, we are dedicated to developing novel cytokine-based therapies to dramatically improve outcomes for patients living with cancer, offering hope where traditional treatments have fallen short.